Active surveillance for prostate cancer: overview and update.
about
Potential Utility of Novel Biomarkers in Active Surveillance of Low-Risk Prostate CancerProstate Cancer Patient Perspectives on the Use of Information in Treatment Decision-Making: A Systematic Review and Qualitative Meta-synthesisThe role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillanceHigh miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomyGenetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients.The potential role of lycopene for the prevention and therapy of prostate cancer: from molecular mechanisms to clinical evidence.An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy.Prostate cancer: a review of active surveillance.Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance.Active surveillance as a therapeutic option for patients with low-risk prostate cancer according to the 2014 International Society of Urological Pathology grading system: a review.Active surveillance in Canadian men with low-grade prostate cancer.DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer.Does comorbidity interact with prostate cancer to increase mortality? A Danish cohort study of 45 326 prostate cancer patients diagnosed during 1995-2011.Role for (11)C-choline PET in active surveillance of prostate cancer.Long-term differences in urinary, bowel and sexual function among men treated with surgery versus radiation for prostate cancer.Upper limit of cancer extent on biopsy defining very low-risk prostate cancer.Total energy expenditure and vigorous-intensity physical activity are associated with reduced odds of reclassification among men on active surveillance.Quality of Life Among Black Prostate Cancer Survivors: An Integrative ReviewProlaris Cell Cycle Progression Test for Localized Prostate Cancer: A Health Technology Assessment
P2860
Q26784517-85EC48F2-D8B4-48D1-B05E-76A29F7A0428Q33746417-8E30BEA6-AE21-4C94-823C-6CEE906E94ABQ34864876-596AC404-20C4-46D7-BD85-D0E6895DFA44Q35443808-969178D7-C448-4BEA-8A0D-DD573522E3CAQ37327993-CD87D33E-8028-4581-98AB-BA2E3AE25524Q38121775-31A82A12-DF11-4A36-9127-64F1B22EF618Q38192714-BF60BA77-A850-44FA-B255-B38DC4F7A1D7Q38247297-1E5ACE66-1F95-4D78-8A21-09004839CC01Q38392814-010095C2-3056-400D-990E-40F8FFE6E8BFQ39038245-E52C8117-6E43-4ED0-BB21-6740C8461A3CQ39958888-0B314A65-D77A-4CAB-9494-2B19052EF795Q40581966-BA848F1A-5765-4D31-BE14-F4E1C970DC74Q41073571-6A141EE8-F7A6-4123-B952-6F5BF8DD2DDAQ41111232-632007DB-F3BA-4563-9F42-1069695B697CQ41821490-D8F82E02-BB09-4630-B715-C9502B9F638BQ42140340-E96C8AD6-FBB6-451B-A834-7DA607FEEFFCQ48248936-2E63382D-9AB8-4D73-B764-8F9D3FA009F1Q49835347-60DD576A-B27D-497D-9C27-FB8ECAF3FEBEQ57106565-EA7ECB92-B9A1-470C-9057-BA1A8267871CQ57117462-9FB80805-2E8B-4DC6-B4C6-125A77D3BC45
P2860
Active surveillance for prostate cancer: overview and update.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Active surveillance for prostate cancer: overview and update.
@en
type
label
Active surveillance for prostate cancer: overview and update.
@en
prefLabel
Active surveillance for prostate cancer: overview and update.
@en
P2860
P1476
Active surveillance for prostate cancer: overview and update.
@en
P2860
P2888
P304
P356
10.1007/S11864-012-0221-5
P577
2013-03-01T00:00:00Z
P6179
1045018284